Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies
NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC
Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects
Controlling Diabetes May Cut Liver Cancer Risk, Study Finds
Colorectal Cancer Screening Practices Need Improvement, CDC Practice Study Finds
Healthcare Utilization Figures More Than Biology In Disparity
Phase III Lung and Pancreatic Cancer Trials Are Stopped
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- House GOP leaders propose “streamlining” NIH into 15 institutes and centers
Plan calls for slashing ARPA-H, adding oversight to infectious disease research - Robert L. Ferris named executive director of UNC Lineberger—with an additional job as chief of oncology services
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Nathan Berger, founding director of Case Comprehensive Cancer Center, dies at 83